There is significant interest inABBV by institutional investors. The 68.58% of outstanding shares they control represents a greater percentage of ownership than at any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended December 2016, these large investors purchased a net $16.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 13.7 Million shares of AbbVie
SUNAMERICA ASSET MANAGEMENT LLC Bought 7.0 Million shares of AbbVie
UBS ASSET MANAGEMENT (AMERICAS) ... Bought 4.9 Million shares of AbbVie